[1] |
WU Dan,LIANG Shaoshan,XU Feng, et al.
Association of cholesterol crystals in renal tubular lumen and prognosis in patients with IgA nephropathy
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2020, 29(4): 317-322.
|
[2] |
XU Feng,ZENG Caihong.
IgA nephropathy accompanied with acute pyelonephritis
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2020, 29(1): 88-92.
|
[3] |
LUO Huiting, LIANG Shaoshan,LIANG Dandan,et al.
IgA nephropathy with endocapillary hypercellularity and macrophage infiltration
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2019, 28(1): 1-6.
|
[4] |
ZHANG fan,TONG ling,GAO erzhi,et al.
Antiglomerular basement membrane disease combined with IgA nephropathy or membranous nephropathy
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2018, 27(2): 113-118.
|
[5] |
YOU Bing,CHEN Jinsong.
Management of recurrent IgA nephropathy following kidney transplantation
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2018, 27(1): 84-88.
|
[6] |
YANG Liu,WANG Jinquan.
Abnormal complement activation and IgA nephropathy
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2017, 26(3): 273-276.
|
[7] |
YANG Nannan,WANG Jinquan.
The intestinal mucosal immune dysfunction and IgA nephropathy
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2016, 25(5): 470-474.
|
[8] |
LIANG Shaoshan,ZENG Caihong.
Coexistence of Fabry disease and IgA nephropathy
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2015, 24(6): 578-581.
|
[9] |
LI Xiaowei|CHENG Shuiqin|LIANG Shaoshan|et al.
The comparison of clinico-pathological features and outcome between IgA nephropathy with minimal change disease and minimal change disease
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2015, 24(5): 401-406.
|
[10] |
Jin Bo|Liang Shaoshan|Chen Hao|et al.
Clinicopathologic characteristics and long-term renal survival of elderly patients with IgA Nephropathy
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2014, 23(5): 412-417.
|
[11] |
SHEN Xiahong| XU Feng| AN Yu| et al.
Clinicopathologic Features and Prognosis of the Patients with IgA Nephropathy Superimposed on Diabetic Nephropathy
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2014, 23(2): 101-107.
|
[12] |
SHEN Xiahong , LIANG Shaoshan , LE Weibo, et al.
Clinicopathologic features and treatment response in IgA nephropathy
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2013, 22(5): 401-408.
|
[13] |
YAN Qiang, JIANG Hua, SUI Wei-guo,et al.
Expression and significance of GSK-3βand NF-κB in renal tissue with chronic active antibody-mediated rejection
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2013, 22(5): 415-421.
|
[14] |
LI Xiaowei, LIU Zhihong.
Advances in Anti–LAMP-2 autoantibody and ANCA-associated pauci immun glomerulonephritis
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2013, 22(5): 455-460.
|
[15] |
SHEN Xiahong, LIU Zhihong.
Oxford Classi?cation of IgA Nephropathy and the Validation Studies
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2013, 22(5): 461-465.
|